| 12357684 |
Modified RSV F proteins and methods of their use |
Yingyun Wu, Michael J. MASSARE, Ye Liu, Gale Smith, Bin Zhou |
2025-07-15 |
|
| 12303560 |
Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus |
Irina Tretyakova |
2025-05-20 |
|
| 11911461 |
Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use |
David C. Wright, Michael Bowe, Emily Wright |
2024-02-27 |
|
| 11576965 |
Recombinant bovine immunodeficiency virus gag virus-like particles containing influenza immunogens |
Irina Tretyakova |
2023-02-14 |
|
| 11446374 |
Modified RSV F proteins and methods of their use |
Yingyun Wu, Michael J. MASSARE, Ye Liu, Gale Smith, Bin Zhou |
2022-09-20 |
$53,760,000 |
| 11058759 |
Vaccines against infectious diseases caused by positive stranded RNA viruses |
Irina Tretyakova |
2021-07-13 |
|
| 11052146 |
Modified RSV F proteins and methods of their use |
Yingyun Wu, Michael J. MASSARE, Ye Liu, Gale Smith, Bin Zhou |
2021-07-06 |
$449,179,000 |
| 10729760 |
Functional influenza virus like particles (VLPs) |
Gale Smith, Rick Bright, Jinyou Zhang, Kutub Mahmood |
2020-08-04 |
$200,803,000 |
| 10653769 |
iDNA vaccines and methods for using the same |
Igor Lukashevich |
2020-05-19 |
|
| 10548968 |
Functional influenza virus-like particles (VLPS) |
Gale Smith, Rick Bright, Jinyou Zhang, Kutub Mahmood |
2020-02-04 |
$10,060,000 |
| 10544399 |
Highly efficient influenza matrix (M1) proteins |
Gale Smith, Yingyun Wu, Michael J. MASSARE, Margaret Nathan, Thomas Kort +1 more |
2020-01-28 |
$11,655,000 |
| 10188723 |
Functional influenza virus like particles (VLPs) |
Gale Smith, Rick Bright, Jinyou Zhang, Kutub Mahmood |
2019-01-29 |
$16,195,000 |
| 10022437 |
Modified RSV F proteins and methods of their use |
Yingyun Wu, Michael J. MASSARE, Ye Liu, Gale Smith, Bin Zhou |
2018-07-17 |
$12,057,000 |
| 9968672 |
IDNA vaccines and methods for using the same |
Igor Lukashevich |
2018-05-15 |
|
| 9956280 |
Functional influenza virus-like particles (VLPs) |
Robin Robinson |
2018-05-01 |
$14,078,000 |
| 9951317 |
Highly efficient influenza matrix (M1) proteins |
Gale Smith, Yingyun Wu, Michael J. MASSARE, Margaret Nathan, Thomas Kort +1 more |
2018-04-24 |
$14,743,000 |
| 9937253 |
Functional influenza virus-like particles (VLPS) |
Gale Smith, Rick Bright, Jinyou Zhang, Kutub Mahmood |
2018-04-10 |
$15,320,000 |
| 9731000 |
Modified RSV F proteins and methods of their use |
Yingyun Wu, Michael J. MASSARE, Ye Liu, Gale Smith, Bin Zhou |
2017-08-15 |
$8,878,000 |
| 9717786 |
Modified RSV F proteins and methods of their use |
Yingyun Wu, Michael J. MASSARE, Ye Liu, Gale Smith, Bin Zhou |
2017-08-01 |
$8,818,000 |
| 9694066 |
Functional influenza virus like particles (VLPs) |
Gale Smith, Rick Bright, Jinyou Zhang, Kutub Mahmood |
2017-07-04 |
|
| 9694065 |
Infectious DNA vaccines against chikungunya virus |
Irina Tretyakova, Igor Lukashevich |
2017-07-04 |
|
| 9675685 |
Modified RSV F proteins and methods of their use |
Yingyun Wu, Michael J. MASSARE, Ye Liu, Gale Smith, Bin Zhou |
2017-06-13 |
$8,314,000 |
| 9623104 |
Functional influenza virus-like particles (VLPS) |
Gale Smith, Rick Bright, Jinyou Zhang, Kutub Mahmood |
2017-04-18 |
$6,609,000 |
| 9474799 |
Functional influenza virus-like particles (VLPS) |
Robin Robinson |
2016-10-25 |
$11,103,000 |
| 9464276 |
Highly efficient influenza matrix (M1) proteins |
Gale Smith, Yingyun Wu, Michael J. MASSARE, Margaret Nathan, Thomas Kort +1 more |
2016-10-11 |
$12,686,000 |